NCT00640822View on ClinicalTrials.gov

Efficacy and Safety of Calcipotriol Plus Hydrocortisone Ointment Compared With Tacalcitol Ointment in Patients With Psoriasis on the Face and Skin Folds

PHASE3CompletedINTERVENTIONAL
Enrollment

782

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

June 30, 2009

Study Completion Date

July 31, 2009

Conditions
Psoriasis Vulgaris
Interventions
DRUG

Calcipotriol plus hydrocortisone ointment vehicle

Once daily application for up to 8 weeks

DRUG

Tacalcitol Ointment

Once daily application for up to 8 weeks

DRUG

Calcipotriol plus hydrocortisone ointment

Once daily application for up to 8 weeks

Trial Locations (3)

N2J1C4

Probity Medical Research, Waterloo

06202

Hôpital de l'Archet, Nice

DD1 9SY

Ninewells Hospital & Medical School, Dundee

Sponsors

Lead Sponsor

LEO Pharma
All Listed Sponsors
lead

LEO Pharma

INDUSTRY

NCT00640822 - Efficacy and Safety of Calcipotriol Plus Hydrocortisone Ointment Compared With Tacalcitol Ointment in Patients With Psoriasis on the Face and Skin Folds | Biotech Hunter | Biotech Hunter